"On balance, we do not like the risk/reward balance in Lilly shares," the analysts wrote.
Get this delivered to your inbox, and more info about our products and services.
Eli Lilly entered Thursday well off its highs. A blowout quarter shows the market got this one wrong.
Wall Street is optimistic heading into Eli Lilly's second-quarter earnings report.
Leerink Partners sees shares of Eli Lilly adding another 19% from here.
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…
The once-loved stock is on pace for its third worst session since 1972.
